UMediC Group Berhad Balance Sheet Health
Financial Health criteria checks 6/6
UMediC Group Berhad has a total shareholder equity of MYR74.6M and total debt of MYR680.0K, which brings its debt-to-equity ratio to 0.9%. Its total assets and total liabilities are MYR83.3M and MYR8.7M respectively. UMediC Group Berhad's EBIT is MYR10.9M making its interest coverage ratio 99.9. It has cash and short-term investments of MYR14.4M.
Key information
0.9%
Debt to equity ratio
RM 680.00k
Debt
Interest coverage ratio | 99.9x |
Cash | RM 14.37m |
Equity | RM 74.61m |
Total liabilities | RM 8.68m |
Total assets | RM 83.29m |
Recent financial health updates
No updates
Recent updates
UMediC Group Berhad's (KLSE:UMC) Returns On Capital Not Reflecting Well On The Business
Nov 11UMediC Group Berhad (KLSE:UMC) Hasn't Managed To Accelerate Its Returns
Aug 05We Think You Should Be Aware Of Some Concerning Factors In UMediC Group Berhad's (KLSE:UMC) Earnings
Jun 17UMediC Group Berhad's (KLSE:UMC) Earnings Are Of Questionable Quality
Dec 18Revenue Downgrade: Here's What Analysts Forecast For UMediC Group Berhad (KLSE:UMC)
Dec 12Some Investors May Be Worried About UMediC Group Berhad's (KLSE:UMC) Returns On Capital
Aug 11Robust Earnings May Not Tell The Whole Story For UMediC Group Berhad (KLSE:UMC)
Mar 13Is There An Opportunity With UMediC Group Berhad's (KLSE:UMC) 21% Undervaluation?
Nov 25Financial Position Analysis
Short Term Liabilities: UMC's short term assets (MYR49.7M) exceed its short term liabilities (MYR4.8M).
Long Term Liabilities: UMC's short term assets (MYR49.7M) exceed its long term liabilities (MYR3.9M).
Debt to Equity History and Analysis
Debt Level: UMC has more cash than its total debt.
Reducing Debt: UMC's debt to equity ratio has reduced from 92.9% to 0.9% over the past 5 years.
Debt Coverage: UMC's debt is well covered by operating cash flow (820.1%).
Interest Coverage: UMC's interest payments on its debt are well covered by EBIT (99.9x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/27 11:44 |
End of Day Share Price | 2024/12/27 00:00 |
Earnings | 2024/10/31 |
Annual Earnings | 2024/07/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
UMediC Group Berhad is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Ken-Wern Lim | Affin Hwang Investment Bank |
Siu Li Chua | Hong Leong Investment Bank Berhad |
Chee Siang | Hong Leong Investment Bank Berhad |